FDA Says Antiseptics Need Testing Or Face Reformulation, Relabeling
This article was originally published in The Tan Sheet
Executive Summary
FDA proposes to amend the OTC antiseptic drug product monograph to require more detailed safety and efficacy tests, pointing to mounting data that shows antibacterial wash products could pose health risks and contribute to increase antibacterial resistance.
You may also be interested in...
In Brief: Clearblue estimates weeks, Barry Meltzer dies, P&G eliminating phthalates and triclosan, NPLEx adds Delaware
P&G Clearblue pregnancy test estimates week of conception; AHPA co-founder Meltzer dies; P&G to eliminate phthalates, triclosan; CSPI, Aloe Science Council square off; Delaware joins NPLEx; IADSA focuses on supplement safety guidelines; Pharmavite expands Alabama facility.
J&J Trims Formaldehyde-Releasing Chemicals In Personal Care Items
In response to consumer demand, J&J will remove controversial ingredients from both baby and adult brands, including Aveeno, Clean & Clear, Lubriderm and Neutrogena.
Triclosan Does Not Contribute To Antibacterial Resistance – Study
The Personal Care Products Council and the American Cleaning Institute tout a study they say confirms that consumer use of antimicrobial agents triclosan and triclocarbon does not lead to antibiotic or antibacterial resistance.